ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Women’s health"

  • Abstract Number: 2035 • ACR Convergence 2023

    Intimate Partner Violence Is Associated with a Poorer Health-Related Quality of Life (HR-QoL) in Women with Systemic Lupus Erythematous

    Emmanuel Campos-Tinajero1, Griselda Serna-Peña2, Jorge A. Esquivel-Valerio1, Rodrigo J. Castillo-de la Garza3, Gisela García Arellano4, Pablo Gamez-Siller1, Estefania Aguilar-Rivera5, Patricia L. Gonzalez-Garcia1 and Dionicio A. Galarza-Delgado6, 1Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 2Universidad Autónoma de Nuevo León, Guadalupe, Mexico, 3Universidad Autónoma de Nuevo León, Monterrey, Mexico, 4Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 5Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico, 6Hospital Universitario UANL, Monterrey, Mexico

    Background/Purpose: Systemic lupus erythematosus (SLE) is an inflammatory, multisystemic, chronic disease more prevalent in women and can significantly impact health-related quality of life (HRQoL).1 Sociodemographic…
  • Abstract Number: 0471 • ACR Convergence 2023

    Knowledge and Misconceptions About Contraception Among Individuals with Inflammatory Arthritis and Lupus-like Diseases

    Caroline Siegel1, Medha Barbhaiya2, Lucy Masto1, Amaya Smole1, Bessie Stamm1, Jonah Levine1, Sarah Lieber2, Lisa Mandl2, Michael Lockshin2 and Lisa Sammaritano2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Rheumatologists do not consistently provide contraceptive counseling for patients with systemic rheumatic disease (SRD). As contraception considerations may differ based on SRD, we compared…
  • Abstract Number: 1359 • ACR Convergence 2023

    Association of Menstrual Cycles and Disease Flare Activity in Women with Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Lucy Masto1, Amaya Smole1, Caroline Siegel1, Sarah Lieber2, Sanjana Adurty3, Jonah Levine1, Bessie Stamm1, Lisa Mandl2, Michael Lockshin2, Lisa Sammaritano2 and Medha Barbhaiya2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 3Weill Cornell Medical College, New York, NY

    Background/Purpose: Whether the timing of menstruation impacts disease activity or severity among women with SLE or RA is poorly understood. We evaluated systemic rheumatic disease…
  • Abstract Number: 2295 • ACR Convergence 2023

    Predictors of Adherence to Cervical Cancer Screening Guidelines Among Patients with Systemic Lupus Erythematosus

    Lindsay Cho and Alexandra Legge, Dalhousie University, Halifax, NS, Canada

    Background/Purpose: Women with systemic lupus erythematous (SLE) are at increased risk for cervical dysplasia and cervical cancer. In our jurisdiction, current guidelines recommend that average-risk…
  • Abstract Number: 0472 • ACR Convergence 2023

    Contraception Choices in Individuals with Inflammatory Arthritis and Lupus-like Disease Differ Based on Diagnosis and Teratogen Use

    Caroline Siegel1, Medha Barbhaiya2, Lucy Masto1, Amaya Smole1, Bessie Stamm1, Jonah Levine1, Sarah Lieber2, Lisa Mandl2, Michael Lockshin2 and Lisa Sammaritano2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Individuals with systemic rheumatic disease (SRD) underutilize effective contraception even when prescribed teratogenic medications. As disease-related factors may impact contraception choice, we evaluated the…
  • Abstract Number: 1362 • ACR Convergence 2023

    Improving Reproductive Health Counseling for Pediatric Adolescent Females Prescribed Teratogenic DMARDs

    Rina Ferguson1, Itay Marmor2 and Maleewan Kitcharoensakkul1, 1Washington University/B-JH/SLCH Consortium, St. Louis, MO, 2Dana-Dwek Children's Hospital, Hod Hasharon, Israel

    Background/Purpose: Several rheumatologic medications routinely prescribed to adolescent females are teratogenic. However, there is no standard method to educate our patients and their families about…
  • Abstract Number: 2529 • ACR Convergence 2023

    Comparative Effectiveness of Denosumab versus Zoledronic Acid Among Postmenopausal Women with Osteoporosis in the U.S. Medicare Program

    Jeffrey R Curtis1, Tarun Arora2, Ye Liu3, Vanessa C. Brunetti4, Tzu-Chieh Lin4, Leslie Spangler4, Robert K. Stad4, Michele McDermott4, Brian D. Bradbury4 and Min Kim4, 1Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, AL, 2Foundation for Advancing Science, Technology, Education, and Research, Birmingham, AL, 3University of Alabama at Birmingham, Birmingham, AL, 4Amgen, Inc., Thousand Oaks, CA

    Background/Purpose: Although clinical trials have shown that denosumab (Dmab) significantly increases bone mineral density at key skeletal sites more than zoledronic acid (ZA), evidence from…
  • Abstract Number: 0475 • ACR Convergence 2023

    Prevalence of Endometriosis and Polycystic Ovarian Syndrome in Patients with Rheumatic Diseases in the United States

    Sabahat Usmani1, Catherine Lavallee2, Maria Antonelli3 and Cuoghi Edens4, 1Weiss Memorial Hospital, Chicago, IL, 2Virginia Tech Carilion School of Medicine, Roanoke, VA, 3MetroHealth System, Cleveland, OH, 4University of Chicago, Chicago, IL

    Background/Purpose: Endometriosis (ENDO) and Polycystic Ovarian Syndrome (PCOS) are underdiagnosed, often debilitating conditions with unknown etiologies that, like rheumatic diseases, affect reproductive-aged women. Recent studies…
  • Abstract Number: 1363 • ACR Convergence 2023

    Plasma Neutrophil Extracellular Trap Remnant Levels Are Lower in Premenopausal Healthy Women Using Oral Contraceptive Pills

    Background/Purpose: Women develop RA 3 times more often than men, and several risk factors for RA are female specific. Prior studies demonstrate an association between…
  • Abstract Number: 0943 • ACR Convergence 2022

    Increased Prevalence of Thrombotic Events in Anti-Phospholipid Antibody-Positive SLE Patients on Estrogen-Containing Contraception

    Hiba Bilal1, Amarah Baluch2 and Andras Perl3, 1SUNY Upstate Medical Unviersity, Jamesville, NY, 2SUNY Upstate Medical University, Syracuse, NY, 3SUNY, Syracuse, NY

    Background/Purpose: Women of child-bearing age with underlying rheumatic disease such as systemic lupus erythematous (SLE) with positive anti-phospholipid antibodies (aPL) are at an increased risk…
  • Abstract Number: PP13 • ACR Convergence 2022

    How Becoming Engaged in My Care with Specialized Tools and Support Helped Me Find My Personal Lupus Triggers and Regain Control of My Health

    Tonya Hinton-Green, Philadelphia, PA

    Background/Purpose: My story begins in the ER where I was diagnosed with lupus right after my 22nd birthday.For the next 25 years I went from…
  • Abstract Number: 0944 • ACR Convergence 2022

    Inconsistent Family Planning Documentation in Women with Interstitial Pneumonia with Autoimmune Features (IPAF)

    Elena Joerns1, Brooke Mills2, Una Makris3, Traci Adams1 and Bonnie Bermas1, 1UT Southwestern, Dallas, TX, 2UT Southwestern Medical Center, Fort Worth, TX, 3UT Southwestern Medical Center and Dallas VA, Dallas, TX

    Background/Purpose: Family planning discussions improve pregnancy outcomes in women with interstitial lung disease (ILD). Women with interstitial pneumonia with autoimmune features (IPAF), a subset of…
  • Abstract Number: 0946 • ACR Convergence 2022

    The Impact of Pregnancy Planning and Medical Readiness on Reproductive Outcomes in Women with SLE

    Catherine Sims1, Amanda Eudy2, Jayanth Doss1, Lisa Criscione-Schreiber3, Kai Sun3, Rebecca Sadun1, Jennifer L Rogers4 and Megan Clowse1, 1Duke University, Durham, NC, 2Duke University, Raleigh, NC, 3Duke University School of Medicine, Durham, NC, 4Duke University School of Medicine, Division of Rheumatology & Immunology, Durham, NC

    Background/Purpose: The ACR Reproductive Health Guidelines recommend that a woman conceive when her SLE is quiescent, she is not taking a teratogenic medication, and that…
  • Abstract Number: 0947 • ACR Convergence 2022

    Development of a Person-Centered Family Planning Decision Aid for Women with Rheumatic Diseases

    Mehret Birru Talabi1, Traci Kazmerski2, Raelynn O'Leary3, Ashley Deal3, Megan Clowse4, Oilvia Stransky5 and Sonya Borrero5, 1University of Pittsburgh, Pittsburgh, PA, 2Children's Hospital of Pittsburgh, Pittsburgh, 3Carnegie Mellon University School of Design, Pittsburgh, 4Duke University, Durham, NC, 5University of Pittsburgh, Pittsburgh

    Background/Purpose: Given the potential for pregnancy-associated mortality and morbidity, the question of whether and/or when to become pregnant is often a profoundly important decision for…
  • Abstract Number: 0948 • ACR Convergence 2022

    Fertility and the Use of Assisted Reproductive Technologies: Perceptions, Thoughts and Experiences of Men and Women with Rheumatic Disease

    Emily Peninger1, Molly Leavitt1, Cuoghi Edens1 and Shilpa Venkatachalam2, 1University of Chicago, Chicago, IL, 2Global Healthy Living Foundation, New York, NY

    Background/Purpose: Patients with rheumatic diseases have fewer biologic children than those without for a number of reasons, including infertility. Patients with rheumatic diseases may therefore…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology